Cite

HARVARD Citation

    Gagelmann, N. et al. (2022). Access to and affordability of CAR T-cell therapy in multiple myeloma: an EBMT position paper. Lancet. 9 (10), pp. e786-e795. [Online]. 
  
Back to record